Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Leishmaniasis; Leishmaniasis, Cutaneous; Wounds and Injuries | Phase 2 | ClinicalTrials |
| Leishmaniasis; Leishmaniasis, Cutaneous | Phase 2/Phase 3 | ClinicalTrials |
| Acquired Immunodeficiency Syndrome; HIV Infections | Phase 2 | ClinicalTrials |
| Acquired Immunodeficiency Syndrome; Communicable Diseases; HIV Infections; Infection | Phase 1 | ClinicalTrials |
| Acquired Immunodeficiency Syndrome; HIV Infections | Phase 3 | ClinicalTrials |
| Rhinitis; Rhinitis, Allergic | Phase 2 | ClinicalTrials |
CONTENTS